PIMJS
ALNY icon

PKO Investment Management Joint-Stock’s Alnylam Pharmaceuticals ALNY Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Buy
7,500
+700
+10% +$211K 0.16% 111
2026
Q1 		$2.25M Hold
6,800
– – 0.19% 103
2025
Q4 		$2.7M Buy
6,800
+6,000
+750% +$2.66M 0.22% 96
2025
Q3 		$365K Buy
+800
New +$326K 0.03% 184

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PKO Investment Management Joint-Stock's ALNY Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Alnylam Pharmaceuticals (ALNY) stake by 10% in Q2 2026, buying an estimated $211K and bringing the position to 7,500 shares worth $2.26M. The position accounts for 0.16% of the portfolio, ranked #111.

PKO Investment Management Joint-Stock first reported a position in ALNY in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.7M in Q4 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • PKO Investment Management Joint-Stock held 7,500 shares of Alnylam Pharmaceuticals worth $2.26M as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 700 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $211K.
  • Alnylam Pharmaceuticals made up 0.16% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #111 holding.
  • PKO Investment Management Joint-Stock first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • PKO Investment Management Joint-Stock's Alnylam Pharmaceuticals position peaked at $2.7M in Q4 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.